TR199902550T2 - 5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri. - Google Patents

5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri.

Info

Publication number
TR199902550T2
TR199902550T2 TR1999/02550T TR9902550T TR199902550T2 TR 199902550 T2 TR199902550 T2 TR 199902550T2 TR 1999/02550 T TR1999/02550 T TR 1999/02550T TR 9902550 T TR9902550 T TR 9902550T TR 199902550 T2 TR199902550 T2 TR 199902550T2
Authority
TR
Turkey
Prior art keywords
compound
ikleri
bstit
pirimidin
aminopyrido
Prior art date
Application number
TR1999/02550T
Other languages
English (en)
Turkish (tr)
Inventor
S. Bhagwat Shripad
J. Perner Richard
Gui Gu Yu
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR199902550T2 publication Critical patent/TR199902550T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1999/02550T 1997-04-16 1998-04-13 5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri. TR199902550T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
TR199902550T2 true TR199902550T2 (xx) 2000-04-21

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02550T TR199902550T2 (xx) 1997-04-16 1998-04-13 5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri.

Country Status (19)

Country Link
EP (1) EP0975633A1 (ja)
JP (1) JP2001520654A (ja)
KR (1) KR20010006462A (ja)
CN (1) CN1252069A (ja)
AR (1) AR012437A1 (ja)
AU (1) AU741033B2 (ja)
BG (1) BG103853A (ja)
BR (1) BR9809056A (ja)
CA (1) CA2286592A1 (ja)
CO (1) CO4940470A1 (ja)
HU (1) HUP0001443A3 (ja)
IL (1) IL131617A0 (ja)
NO (1) NO995035L (ja)
NZ (1) NZ337125A (ja)
PL (1) PL336265A1 (ja)
SK (1) SK140099A3 (ja)
TR (1) TR199902550T2 (ja)
WO (1) WO1998046604A1 (ja)
ZA (1) ZA983175B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
CA2434834C (en) 2001-02-12 2010-09-14 F. Hoffmann-La Roche Ag 6-substituted pyrido-pyrimidines
CN107744520A (zh) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 嘧啶类化合物在制备促进小肠蠕动药物中的应用
CN112209924B (zh) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 选择性腺苷a1受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
CA2286592A1 (en) 1998-10-22
EP0975633A1 (en) 2000-02-02
KR20010006462A (ko) 2001-01-26
ZA983175B (en) 1998-10-21
PL336265A1 (en) 2000-06-19
JP2001520654A (ja) 2001-10-30
BR9809056A (pt) 2000-08-01
CO4940470A1 (es) 2000-07-24
CN1252069A (zh) 2000-05-03
AR012437A1 (es) 2000-10-18
BG103853A (en) 2000-06-30
AU741033B2 (en) 2001-11-22
NO995035L (no) 1999-12-15
AU7108098A (en) 1998-11-11
NZ337125A (en) 2001-06-29
HUP0001443A3 (en) 2001-01-29
SK140099A3 (en) 2000-05-16
HUP0001443A2 (hu) 2000-10-28
WO1998046604A1 (en) 1998-10-22
IL131617A0 (en) 2001-01-28
NO995035D0 (no) 1999-10-15

Similar Documents

Publication Publication Date Title
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
CA2216796A1 (en) Quinazoline derivatives
CA2098076A1 (en) Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
NO914036L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
CA2111836A1 (en) Spin-trapping pharmaceutical compositions and methods for use thereof
CA2140106A1 (en) Method of treating hyperproliferative vascular disease
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
TR199902455T2 (xx) 5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m�
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
CA2036618A1 (en) Fused thiophene derivatives, their production and use
EP2082740A3 (en) Use of imidazole derivatives as MDR modulators
TR199902550T2 (xx) 5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
EP0793497A4 (en) NOVEL IMINATED QUINONE ENEDIYNE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE OF SUCH COMPOUNDS
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
DE69122858D1 (de) Therapeutische benzazepin verbindungen
TR199902456T2 (xx) 6,7-ikameli-4-aminopirido$2,3,-D]Pirimidin bile�ikleri.
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
MY104829A (en) 3-phenyl-5, 6-dihydrobenz [c]acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents.
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
DE69813886D1 (de) Naphthalin derivate